n-glycolylneuraminic acid has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boligan, KF; Bovin, N; Cummings, RD; Kappos, L; Keller, CW; Kuhle, J; Lünemann, JD; Oechtering, J; Peschke, B; Rieben, R; von Gunten, S | 1 |
1 other study(ies) available for n-glycolylneuraminic acid and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS.
Topics: Adult; Autoantibodies; Biomarkers; Epitopes; Female; Humans; Immunoglobulin G; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; N-Acetylneuraminic Acid; Neuraminic Acids | 2020 |